Jan 29 (Reuters) -
* LIMFLOW COMPLETES ENROLLMENT IN US FEASIBILITY STUDY AND RECEIVES BREAKTHROUGH DEVICE STATUS FROM FDA FOR ITS PERCUTANEOUS DEEP VEIN ARTERIALIZATION (PDVA) SYSTEM Source text for Eikon:
 